de Freitas, Ana SofiaÁlvarez Larrán, Alberto2017-03-142016de Freitas AS, Alvarez-Larrán A. Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants. Ann Hematol. 2016 Oct;95(11):1903-4. DOI: 10.1007/s00277-016-2783-y0939-5555http://hdl.handle.net/10230/28224Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by an expansion of red cell mass which leads to an increased risk of thrombotic and hemorrhagic complications.application/pdfeng© Springer The final publication is available at Springer via http://dx.doi.org/10.1007/s00277-016-2783-yTrombosiHemorràgiaPolicitèmia veraRisk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.info:eu-repo/semantics/articlehttp://dx.doi.org/10.1007/s00277-016-2783-yinfo:eu-repo/semantics/openAccess